Healthcare group Ascendis saw a drop in its profit in its interim results as management continued to trim the business amid a shift in its balance sheet, including selling its pharma segment and paying off its debt.
The company, valued at R386m on the JSE, said in its results for the six months endedDecember that gross profit, revenues minus the cost of sales, declined 8.6% to R311.9m, while profit for the period, helped by its discontinued operations, fell 41% to R189.9m...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: